NFA
CRL icon

Nationwide Fund Advisors’s Charles River Laboratories CRL Stock Holding History

Nationwide Fund Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-80,302
Closed -$8.67M – 475
2017
Q3 		$8.67M Sell
80,302
-699
-0.9% -$71.8K 0.03% 735
2017
Q2 		$8.19M Buy
81,001
+2,160
+3% +$199K 0.03% 747
2017
Q1 		$7.09M Buy
78,841
+161
+0.2% +$13.7K 0.03% 822
2016
Q4 		$6M Sell
78,680
-18,977
-19% -$1.44M 0.02% 899
2016
Q3 		$8.14M Buy
97,657
+11,864
+14% +$995K 0.03% 722
2016
Q2 		$7.07M Buy
85,793
+8,535
+11% +$703K 0.03% 767
2016
Q1 		$5.87M Buy
77,258
+2,615
+4% +$194K 0.03% 845
2015
Q4 		$6M Sell
74,643
-45
-0.1% -$3.25K 0.03% 831
2015
Q3 		$4.74M Sell
74,688
-1,029
-1% -$73.9K 0.02% 940
2015
Q2 		$5.33M Sell
75,717
-1,881
-2% -$139K 0.02% 931
2015
Q1 		$6.15M Buy
77,598
+951
+1% +$70.2K 0.02% 877
2014
Q4 		$4.88M Sell
76,647
-327
-0.4% -$20.5K 0.02% 957
2014
Q3 		$4.6M Sell
76,974
-2,253
-3% -$129K 0.02% 992
2014
Q2 		$4.24M Sell
79,227
-138
-0.2% -$7.57K 0.02% 1081
2014
Q1 		$4.79M Sell
79,365
-2,005
-2% -$117K 0.02% 888
2013
Q4 		$4.32M Sell
81,370
-2,536
-3% -$127K 0.02% 1036
2013
Q3 		$3.88M Buy
83,906
+2,022
+2% +$92.8K 0.02% 1051
2013
Q2 		$3.36M Buy
+81,884
New +$3.51M 0.02% 1027

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nationwide Fund Advisors's CRL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Charles River Laboratories (CRL) in Q4 2017, closing a stake of 80,302 shares — an estimated $8.67M sold.

Nationwide Fund Advisors first reported a position in CRL in Q2 2013 and held it in 18 quarters. The position peaked at $8.67M in Q3 2017. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Charles River Laboratories position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 80,302 Charles River Laboratories shares in Q4 2017, an estimated $8.67M.
  • Nationwide Fund Advisors first reported a position in Charles River Laboratories in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Charles River Laboratories position peaked at $8.67M in Q3 2017.
  • 339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.